title: Intravitreal bevacizumab for idiopathic choroidal neovascularization.
abstract: An otherwise healthy 8-year-old girl with active juxtapapillary choroidal neovascularization was successfully treated with two intravitreal injections of bevacizumab. Intravitreal bevacizumab was well tolerated, choroidal neovascularization involuted, and subretinal and intraretinal serous fluid resorbed, with improvement in visual acuity from 20/400 to 20/50. The girl has remained stable for 6 months after the injections.
authors.affiliation: Beyoğlu Eye Training and Research Hospital, Istanbul, Turkey. drmcakir@hotmail.com
authors.forename: Mehmet
authors.initials: M
authors.lastname: Cakir
authors.forename: Osman
authors.initials: O
authors.lastname: Cekiç
authors.forename: O Faruk
authors.initials: OF
authors.lastname: Yilmaz
mesh_terms: D020533:Angiogenesis Inhibitors / Q000008:administration & dosage*; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D002648:Child; D020256:Choroidal Neovascularization / Q000188:drug therapy* / Q000473:pathology; D005260:Female; D006801:Humans; D007267:Injections; D014792:Visual Acuity / Q000187:drug effects*; D014822:Vitreous Body
chemical_list: D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab